PMC:7534795 / 10113-10296
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T91","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk for developing severe complications (Huang et al., 2020; Wang, Hu, et al., 2020)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T55","span":{"begin":0,"end":183},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk for developing severe complications (Huang et al., 2020; Wang, Hu, et al., 2020)."}
2_test
{"project":"2_test","denotations":[{"id":"33031856-31986264-84038824","span":{"begin":153,"end":157},"obj":"31986264"},{"id":"33031856-32031570-84038825","span":{"begin":177,"end":181},"obj":"32031570"}],"text":"However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk for developing severe complications (Huang et al., 2020; Wang, Hu, et al., 2020)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"378","span":{"begin":54,"end":62},"obj":"Species"},{"id":"396","span":{"begin":45,"end":53},"obj":"Disease"},{"id":"397","span":{"begin":79,"end":82},"obj":"Disease"}],"attributes":[{"id":"A378","pred":"tao:has_database_id","subj":"378","obj":"Tax:9606"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"MESH:C000657245"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk for developing severe complications (Huang et al., 2020; Wang, Hu, et al., 2020)."}